How do we reasonably and accurately balance the risks of the AstraZeneca vaccine against the benefits? Conceptualising risk can be tricky, but the government's latest advice is sensible.
We need to stop relying on small GP clinics and urgently move towards using mass vaccination hubs like stadiums, schools and parks.
In-person learning can safely resume as long as schools take steps to mitigate the spread of COVID-19.
These mistakes have been mainly caused by our leaders giving priority to a good political story over good policy.
The development of the COVID-19 vaccines is part of a vast system of public subsidies and universities, not corporate ambition.
For people who are immunodeficient, the usual controls of the immune system don't work as well. This can affect how they respond to vaccines. But this group should still get the COVID jab.
Researchers in the US are the first to study how pregnant and breast-feeding women are responding to the vaccines. The results are promising
Adjuvants have been giving vaccines their oomph since 1925.
People who have had COVID will still benefit from having a COVID vaccine. Here's why.
From today, around 1,000 clinics around the country can begin vaccinating eligible Australians.
Solar-powered cold chain technologies can be game-changers in the fight against COVID-19 in resource-limited settings in sub-Saharan Africa and beyond.
As immunisation emerges as the world's primary weapon to combat COVID-19, much more work is needed to improve electricity access so vaccines can be refrigerated.
It's not too late for Australia to repair our vaccine strategy, though we will never make up for the months lost.
Divisions among Catholics have created doubts about the moral acceptability of one of the COVID-19 vaccines. An expert explains why there isn't one 'Catholic view' on the issue.
The government should be explicit about what proportion of the population will need to be vaccinated to warrant border reopening. Australians could then measure progress towards that goal.
Decades of experience with influenza offers insights into how we should handle new SARS-CoV-2 variants, and the threat they pose to vaccine effectiveness.
Several countries on the continent had introduced COVID-19 vaccination by early March 2021.
Is Australia behind on its rollout of the COVID-19 vaccine? Yes. Will it catch up? Most likely, yes. But there are perils in trying to go too fast, and in overpromising on deadlines.
An out-of-control COVID epidemic in PNG would be a humanitarian and economic disaster for the nation itself, and a grave threat to the region.
The group has been at pains to stress it is not fundamentally about countering the 'Chinese threat'. But of course, that is primarily what it is about.